Nitrosamines are carcinogenic compounds that can be found and formed in many products.  This has been a particular issue in the pharmaceutical industry recently. Traditional approaches to the analysis, such as by mass spec, have been challenging due to the low detection levels required, the possibility of false positives, or even missing.